Selected research
Industry Research
Nodoame Industry Research Report 2026
Market perspective
The global Nodoame market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Nodoame is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Nodoame is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Nodoame is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Nodoame include Comvita, Vocalzone, Good Health, Kanro, UHA Mikakuto Co.,Ltd, RYUKAKUSAN Co.,Ltd., Zirkulin, Ricola and Fisherman's Friend, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Nodoame market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nodoame Market by Company
Comvita
Vocalzone
Good Health
Kanro
UHA Mikakuto Co.,Ltd
RYUKAKUSAN Co.,Ltd.
Zirkulin
Ricola
Fisherman's Friend
Golden Throat Holdings Group Company Limited
Nin Jiom
Wong Lo Kat
Poon Goor Soe
Guilin Sanjin Pharmaceutical Company Limited
Nodoame Segment by Type
Medicinal
Food
Nodoame Segment by Application
Supermarket
Drugstore
Nodoame Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nodoame market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nodoame and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nodoame.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Nodoame manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Nodoame by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Nodoame in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Medicinal
- Food
Applications
- Supermarket
- Drugstore
Companies covered
- Comvita
- Vocalzone
- Good Health
- Kanro
- UHA Mikakuto Co.,Ltd
- RYUKAKUSAN Co.,Ltd.
- Zirkulin
- Ricola
- Fisherman's Friend
- Golden Throat Holdings Group Company Limited
- Nin Jiom
- Wong Lo Kat
- Poon Goor Soe
- Guilin Sanjin Pharmaceutical Company Limited
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Nodoame Market Size (2021-2032)
- 2.2.2 Global Nodoame Sales (2021-2032)
- 2.2.3 Global Nodoame Market Average Price (2021-2032)
- 2.3 Nodoame by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Medicinal
- 2.3.3 Food
- 2.4 Nodoame by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Supermarket
- 2.4.3 Drugstore
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Nodoame Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Nodoame Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Nodoame Revenue of Manufacturers (2021-2026)
- 3.4 Global Nodoame Average Price by Manufacturers (2021-2026)
- 3.5 Global Nodoame Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Nodoame, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Nodoame, Product Type & Application
- 3.8 Global Manufacturers of Nodoame, Established Date
- 3.9 Global Nodoame Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Comvita
- 4.1.1 Comvita Company Information
- 4.1.2 Comvita Business Overview
- 4.1.3 Comvita Nodoame Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Comvita Nodoame Product Portfolio
- 4.1.5 Comvita Recent Developments
- 4.2 Vocalzone
- 4.2.1 Vocalzone Company Information
- 4.2.2 Vocalzone Business Overview
- 4.2.3 Vocalzone Nodoame Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Vocalzone Nodoame Product Portfolio
- 4.2.5 Vocalzone Recent Developments
- 4.3 Good Health
- 4.3.1 Good Health Company Information
- 4.3.2 Good Health Business Overview
- 4.3.3 Good Health Nodoame Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Good Health Nodoame Product Portfolio
- 4.3.5 Good Health Recent Developments
- 4.4 Kanro
- 4.4.1 Kanro Company Information
- 4.4.2 Kanro Business Overview
- 4.4.3 Kanro Nodoame Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Kanro Nodoame Product Portfolio
- 4.4.5 Kanro Recent Developments
- 4.5 UHA Mikakuto Co.,Ltd
- 4.5.1 UHA Mikakuto Co.,Ltd Company Information
- 4.5.2 UHA Mikakuto Co.,Ltd Business Overview
- 4.5.3 UHA Mikakuto Co.,Ltd Nodoame Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 UHA Mikakuto Co.,Ltd Nodoame Product Portfolio
- 4.5.5 UHA Mikakuto Co.,Ltd Recent Developments
- 4.6 RYUKAKUSAN Co.,Ltd.
- 4.6.1 RYUKAKUSAN Co.,Ltd. Company Information
- 4.6.2 RYUKAKUSAN Co.,Ltd. Business Overview
- 4.6.3 RYUKAKUSAN Co.,Ltd. Nodoame Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 RYUKAKUSAN Co.,Ltd. Nodoame Product Portfolio
- 4.6.5 RYUKAKUSAN Co.,Ltd. Recent Developments
- 4.7 Zirkulin
- 4.7.1 Zirkulin Company Information
- 4.7.2 Zirkulin Business Overview
- 4.7.3 Zirkulin Nodoame Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Zirkulin Nodoame Product Portfolio
- 4.7.5 Zirkulin Recent Developments
- 4.8 Ricola
- 4.8.1 Ricola Company Information
- 4.8.2 Ricola Business Overview
- 4.8.3 Ricola Nodoame Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Ricola Nodoame Product Portfolio
- 4.8.5 Ricola Recent Developments
- 4.9 Fisherman's Friend
- 4.9.1 Fisherman's Friend Company Information
- 4.9.2 Fisherman's Friend Business Overview
- 4.9.3 Fisherman's Friend Nodoame Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Fisherman's Friend Nodoame Product Portfolio
- 4.9.5 Fisherman's Friend Recent Developments
- 4.10 Golden Throat Holdings Group Company Limited
- 4.10.1 Golden Throat Holdings Group Company Limited Company Information
- 4.10.2 Golden Throat Holdings Group Company Limited Business Overview
- 4.10.3 Golden Throat Holdings Group Company Limited Nodoame Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Golden Throat Holdings Group Company Limited Nodoame Product Portfolio
- 4.10.5 Golden Throat Holdings Group Company Limited Recent Developments
- 4.11 Nin Jiom
- 4.11.1 Nin Jiom Company Information
- 4.11.2 Nin Jiom Business Overview
- 4.11.3 Nin Jiom Nodoame Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Nin Jiom Nodoame Product Portfolio
- 4.11.5 Nin Jiom Recent Developments
- 4.12 Wong Lo Kat
- 4.12.1 Wong Lo Kat Company Information
- 4.12.2 Wong Lo Kat Business Overview
- 4.12.3 Wong Lo Kat Nodoame Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Wong Lo Kat Nodoame Product Portfolio
- 4.12.5 Wong Lo Kat Recent Developments
- 4.13 Poon Goor Soe
- 4.13.1 Poon Goor Soe Company Information
- 4.13.2 Poon Goor Soe Business Overview
- 4.13.3 Poon Goor Soe Nodoame Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Poon Goor Soe Nodoame Product Portfolio
- 4.13.5 Poon Goor Soe Recent Developments
- 4.14 Guilin Sanjin Pharmaceutical Company Limited
- 4.14.1 Guilin Sanjin Pharmaceutical Company Limited Company Information
- 4.14.2 Guilin Sanjin Pharmaceutical Company Limited Business Overview
- 4.14.3 Guilin Sanjin Pharmaceutical Company Limited Nodoame Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Guilin Sanjin Pharmaceutical Company Limited Nodoame Product Portfolio
- 4.14.5 Guilin Sanjin Pharmaceutical Company Limited Recent Developments
5 Global Nodoame Market Scenario by Region
- 5.1 Global Nodoame Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Nodoame Sales by Region: 2021-2032
- 5.2.1 Global Nodoame Sales by Region: 2021-2026
- 5.2.2 Global Nodoame Sales by Region: 2027-2032
- 5.3 Global Nodoame Revenue by Region: 2021-2032
- 5.3.1 Global Nodoame Revenue by Region: 2021-2026
- 5.3.2 Global Nodoame Revenue by Region: 2027-2032
- 5.4 North America Nodoame Market Facts & Figures by Country
- 5.4.1 North America Nodoame Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Nodoame Sales by Country (2021-2032)
- 5.4.3 North America Nodoame Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Nodoame Market Facts & Figures by Country
- 5.5.1 Europe Nodoame Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Nodoame Sales by Country (2021-2032)
- 5.5.3 Europe Nodoame Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Nodoame Market Facts & Figures by Country
- 5.6.1 Asia Pacific Nodoame Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Nodoame Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Nodoame Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Nodoame Market Facts & Figures by Country
- 5.7.1 South America Nodoame Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Nodoame Sales by Country (2021-2032)
- 5.7.3 South America Nodoame Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Nodoame Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Nodoame Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Nodoame Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Nodoame Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Nodoame Sales by Type (2021-2032)
- 6.1.1 Global Nodoame Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Nodoame Sales Market Share by Type (2021-2032)
- 6.2 Global Nodoame Revenue by Type (2021-2032)
- 6.2.1 Global Nodoame Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Nodoame Revenue Market Share by Type (2021-2032)
- 6.3 Global Nodoame Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Nodoame Sales by Application (2021-2032)
- 7.1.1 Global Nodoame Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Nodoame Sales Market Share by Application (2021-2032)
- 7.2 Global Nodoame Revenue by Application (2021-2032)
- 7.2.1 Global Nodoame Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Nodoame Revenue Market Share by Application (2021-2032)
- 7.3 Global Nodoame Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Nodoame Value Chain Analysis
- 8.1.1 Nodoame Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Nodoame Production Mode & Process
- 8.2 Nodoame Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Nodoame Distributors
- 8.2.3 Nodoame Customers
9 Global Nodoame Analyzing Market Dynamics
- 9.1 Nodoame Industry Trends
- 9.2 Nodoame Industry Drivers
- 9.3 Nodoame Industry Opportunities and Challenges
- 9.4 Nodoame Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst